A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer

Inclusion Criteria

• •1. Aged 18-75 years
• •2. ECOG performance status score of 0 or 1;
• •3. Histopathologically confirmed advanced or metastatic non-small cell lung cancer;
• •4. Participants must provide archived or fresh tumor tissue;
• •5. Participants must have experienced disease progression or intolerance after systemic anti-tumor therapy for advanced or metastatic disease;
• •6. At least one measurable lesion according to RECIST v1.1 criteria;
• •7. Expected survival ≥3 months;
• •8. Adequate organ function;